Ectopic expression of recipient CD47 inhibits mouse macrophage‐mediated immune rejection against human stem cell transplants. Issue 1 (13th July 2018)

• Record Type: Journal Article
• Authors: Leung, Cherry S.; Li, Jiatao; Xu, Feng; Wong, Alan S. L.; Lui, Kathy O.
• Is Part Of: FASEB journal. Volume 33:Issue 1(2019)
• Page Start: 484
• Page End: 493
• Publication Date: 2018-07-13
• Subjects: ESCs -- phagocytosis -- endothelial cells -- immune tolerance -- xenotransplantation; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.201800449R
• Languages: English
• ISSNs: 0892-6638

Abstract

ABSTRACT: Like conventional transplants, immunosuppression is required to facilitate survival and function of human embryonic stem cell (hESC) derivatives after implantation into xenogeneic recipients. We have previously reported that T cells alone are sufficient to reject allogeneic murine ESC derivatives; and strategies that inhibit T‐cell activation, including coreceptor and costimulation blockade, prevent hESC derivatives from being rejected. This study aimed to investigate, in addition to T cells, whether macrophages contribute to transplant rejection of hESC xenografts with nonobese diabetic (NOD)/SCID mice that lack functional T and B cells but have macrophages. We show that acute rejection against hESC‐derived endothelial cells (hESC‐ECs) was mediated, to some degree, by infiltrating macrophages that phagocytosed them. Transgenic expression of murine CD47 on cell surface of hESC‐ECs mitigates macrophage‐mediated phagocytosis and improves their survival after transplantation. Our results highlight that innate immune cells, such as macrophages, can reject hESC derivatives, raising concern against the use of NOD/SCID as transplant recipients for testing in vivo function of hESC‐derived tissues. Augmenting CD47 signaling promotes survival and function of hESC derivatives after xenogeneic transplantation.—Leung, C. S., Li, J., Xu, F., Wong, A. S. L., Lui, K. O. Ectopic expression of recipient CD47 inhibits mouse macrophage‐mediated immune rejection against human stem cell transplants. FASEB J. 33, 484–193 (2019). www.fasebj.org